Skip to main content
. 2021 Apr 16;11(4):1142. doi: 10.3390/ani11041142

Figure 5.

Figure 5

Representation for Interleukin-6 (IL-6) concentration (ng/mL) in the treatment groups. The groups are: the control group (NG); the Cisplatin treated-group (CG); the Cisplatin+ beetroot extract-treated group (CBG); the Cisplatin+ mesenchymal stem cells-treated group (CMG); and the Cisplatin+ mesenchymal stem cells + beetroot extract-treated group (CMBG). The interrelations between all the presented groups are statistically significant (p ≤ 0.05).